Advertisement

Topics

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment ...

22:45 EDT 19 Sep 2018 | BioMedReports - Blog

SUZHOU, China, Sept. 19, 2018 /PRNewswire/ -- Innovent Biologics (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical

Read more...

Original Article: Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment ...

NEXT ARTICLE

More From BioPortfolio on "Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab as the First-line Treatment ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...